Enteroviroses in disguise - Causing more morbidity than previously thought?;Enteroviroser i nya skepnader

Lakartidningen

Volumn , Issue 28-29, 1997, Pages 2555-2560

  Fohlman, Jan ^a,c   Friman, Göran ^a   Tuvemo, Torsten ^b,c  

^a Infektionskliniken ^*  (Sweden)

^b Akademiska Barnsjukhuset   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC FATIGUE SYNDROME; CLASSIFICATION; CONGESTIVE CARDIOMYOPATHY; ENTEROVIRUS; ENTEROVIRUS INFECTION; GENETICS; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; POSTPOLIOMYELITIS SYNDROME; REVIEW; SEROTYPING; VIROLOGY;

CARDIOMYOPATHY, DILATED; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FATIGUE SYNDROME, CHRONIC; HUMANS; POSTPOLIOMYELITIS SYNDROME; SEROTYPING;

EID: 0031561032     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dahlquist G, Blom L, Holmgren G. The epidemiology of diabetes in Swedish children 0-14 years - a six-year prospective study. Diabetologia 1985; 28: 802-8.
2. Ginsberg-Fellner F, Witt ME, Fedun B, Taub F, Dobersen MJ, McEvoy RC et al. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. Review in Infections Diseases 1985; 7 suppl 1: 170-6.
3. Yoon JW, Austin M, Onodera T, Notkins AL. Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300: 1173-9.
4. Fohlman J, Friman G. Is juvenile diabetes a viral disease? Ann Med 1993; 25: 569-74.
5. Rewers M, Atkinson M. The possible role of enteroviruses in diabetes mellitus. In: Rotbart HA, ed. Human enterovirus infections. Washington DC: ASM Press, 1995: 353-85.
6. King M, Bidwell D, Shaikh A, Voller A, Banatvala J. Coxsackie-B-virus-specific IgM responses in children with insulin-dependant (juvenile-onset; type 1) diabetes mellitus. Lancet 1983; 1: 1397-9.
7. Frisk G, Fohlman J, Kobbah M, Ewald U, Tuvemo T, Diderholm H, Friman G. High frequency of Coxsackie-B-virusspecific IgM in children developing type I diabetes during a period of high diabetes morbidity. J Med Virol 1985; 17: 219-27.
8. Frisk G, Friman G, Tuvemo T, Fohlman J, Diderholm H. Coxsackie B virus IgM in children developing insulin dependent diabetes mellitus: evidence for its induction by a recent or current infection. Diabetologia 1992; 35: 249-53.
9. Trägårdh L, Rask L, Wiman K, Fohlman J, Peterson P. Complete amino acid sequence of pooled papain-solubilised HLA-A, B and C antigens: Relatedness to immunoglobulins and internal homologies. Proc Natl Acad Sci 1979; 77: 1129-33.
10. Engelhard VA. Structure of peptides associated with class I and II MHC molecules. Ann Rev Immunol 1994; 12: 181-207.
11. Fohlman J, Böhme J, Rask L, Peterson PA, Frisk G, Diderholm H et al. Matching of host genotype and serotype of Coxsackie B virus in the development of juvenile diabetes. Scand J Immunol 1987; 26: 105-10.
12. Hyöty H, Hiltunen M, Knip M, Laakkonen M, Vähäsalo P, Karjalainen J et al. A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995; 44: 652-7.
13. Dahlquist G. Etiological aspects of insulin dependent diabetes mellitus. Autoimmunity 1993; 15: 61-5.
14. Solimena M, de Camilli P. Coxsackieviruses and diabetes. Nature Medicine 1995; 1: 23-4.
15. Atkinson MA, Bowman M, Campbell L, Darrow BL, Kaufman DL, MacLaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependant diabetes. J Clin Invest 1994; 94: 2125-9.
16. Kandolf R, Klingel K, Zell R, Selinka HC, Raab U, Schneider-Brachert W et al. Molecular pathogenesis of enterovirus-induced myocarditis: Virus persistence and chronic inflammation. Intervirology 1993; 35: 141-51.
17. Why H, Meany B, Richardson P, Olsen E, Bowles N, Cunningham L et al. Clinical and prognostic significance of enteroviral RNA in the myocardium of patients with myocarditis and dilated cardiomyopathy. Circulation 1994; 89: 2582-9.
18. Beck MA, Shi Q, Morris CV, Levander OA. Rapid genornic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nature Medicine 1995; 5: 433-6.
19. Fohlman J, Pauksen K, Ernst A, Eggertsen G, Ilbäck NG, Woods M et al. Treatment of experimental myocarditis with the antiviral WIN 54 954 reduces mortality. Circulation. 1996; 94: 2254-9.
20. Fohlman J, Ilbäck NG, Friman G, Morein B. Vaccination of Balb/c mice against enteroviral mediated myocarditis. Vaccine 1990; 8: 381-4.